Deep Genomics
Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.
Deep Genomics
Deep Genomics is an AI-first TechBio organization pioneering a new path for genomic R&D with its AI foundation model platform. They aim to program therapies for any gene and any genetic condition by untangling the complexity in RNA biology, identifying novel targets, and evaluating thousands of possibilities to identify the best therapeutic candidates. Their proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth, with their foundation model for RNA Biology, BigRNA, released in 2023 and BigRNA+ currently in development. The company has a diverse team of over 100 members with expertise across AI, genomics, drug development, and related fields, and operates from offices in Toronto, Canada, and Boston, USA.